Stacy C. Brecht

Stacy C. Brecht has a diverse work experience in the field of nuclear medicine and market access. Stacy C. currently serves as the Director of Pricing and Market Access at ITM Isotope Technologies Munich SE, where they are responsible for developing pricing and market access strategies for oncologic radiopharmaceutical products. Prior to this role, they ran their own consulting firm, Stacy Brecht Consulting, where they provided expertise in theranostic solutions and assisted in the planning and development of start-up theranostic platforms. Stacy has also worked at Novartis as an Associate Director of Market Access Solutions Management, where they focused on payer relations and obtaining market access for radiopharmaceutical oncologic products. Their previous experience includes positions at Advanced Accelerator Applications, Foundation Radiology Group, UPMC, West Penn Allegheny Health System, Alliance Cardiology, Holy Cross Hospital, and Broward College. Throughout their career, Stacy has demonstrated a strong understanding of the nuclear medicine field and has been involved in various aspects such as reimbursement, clinical research, patient management, and strategic sourcing.

Stacy C. Brecht completed a Master of Business Administration (MBA) degree in Business Administration and Management from Bellevue University from 2020 to 2022. Prior to that, they obtained a Bachelor of Science (B.S.) degree in Information Technology from the same university between 2017 and 2019. Stacy also pursued additional education and certifications, including Computed Tomography training at CCAC from 2014 to 2015 and a Certificate in Nuclear Medicine from 2003 to 2004. Their educational journey began with an Associate of Science (A.S.) degree in Medical Laboratory Science from CCAC, which they obtained between 2001 and 2003. Stacy also holds certifications in Computed Tomography and Nuclear Medicine Board Certification from the Nuclear Medicine Technology Certification Board (NMTCB) obtained in 2017 and 2005, respectively.